Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIPseq for pediatric AML patients

ABSTRACT: Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are to explore ChIPseq results for pediatric AML patients.

ORGANISM(S): Homo sapiens

PROVIDER: GSE188605 | GEO | 2022/07/20

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

ChIPseq for pediatric AML patients

Project description:ChIPseq for pediatric AML patients

| PRJNA779619 | ENA

ChIPseq for NB4 cell line in either the absence or presence of GNE987

Project description:Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are to explore ChIPseq results for NB4 cell line.

2022-07-20 | GSE188750 | GEO

ChIPseq for NB4 cell line with either no treatment or LDB1 overexpression

2022-09-22 | GSE213636 | GEO

RNA-seq for AML samples

Project description:Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are to explore RNA-seq results for AML samples.

2022-07-20 | GSE190775 | GEO

CUT-TAG for AML cell lines

2023-10-30 | GSE246200 | GEO

CUT-TAG for AML cell lines with either no treatment or ANP32B knockdown

2023-09-12 | GSE242532 | GEO

Expression data from pediatric AML patients

Project description:Pediatric acute myeloid leukemia (AML) is a heterogeneous disease characterized by non-random genetic aberrations related to outcome. Detecting these aberrations however still lead to failures or false negative results. Therefore, we focused on the potential of gene expression profiles (GEP) to classify pediatric AML. Gene expression microarray data of 237 children with AML were generated and cases were split into a discovery cohort (n=157) and an independent validation cohort (n=80). Next, a double-loop cross validation approach was used to generate a subtype-predictive GEP in the discovery cohort which was then tested for its true predictive value in the independent validation cohort. 237 bone marrow and peripheral blood samples were collected at diagnosis and frozen. They were later thawed and hybridized to Affymetrix U133 Plus 2.0 arrays.

2010-10-21 | E-GEOD-17855 | biostudies-arrayexpress

Expression data from pediatric AML patients

2010-10-21 | GSE17855 | GEO

Genomic analysis of pediatric AML by whole transcriptome sequencing [pediatric AML patients]

Project description:Pediatric AML is an aggressive hematological malignancy associated with distinctive genomic features. We employed RNA-seq to study fusion genes and clinically relevant gene expression patterns in pediatric AML patients.

2023-05-02 | GSE222814 | GEO

Genomic analysis of pediatric AML by whole transcriptome sequencing [pediatric AML patients]

Project description:Genomic analysis of pediatric AML by whole transcriptome sequencing [pediatric AML patients]

| PRJNA923607 | ENA